The European Union's drug regulator has approved the use of Pfizer-BioNTech's COVID-19 vaccine for children between the ages of 5 and 11. The approval comes as Europe is again the epicenter of the pandemic.

EU regulator gives go-ahead to first COVID-19 shot or 5-11-year-olds

The United States Food and Drug Administration (FDA) granted full approval to Pfizer-BioNTech’s coronavirus vaccine for people 16 and older. This becomes the first vaccine to receive a complete nod.

US FDA grants full approval to Pfizer-BioNTech COVID-19 vaccine

Pfizer eyes $33.5 billion revenue in 2021 amid vaccine sales

Pfizer/BioNTech to produce Covid vaccine in S.Africa

Over 50 million Pfizer vaccines ready to be delivered to India; talks ongoing for 'partial indemnity'

A new British study has found that Pfizer COVID-19 vaccine is more effective if the second dose is delayed to 12-weeks after the first. The study, which has not yet been peer reviewed—found that delaying the second dose to 12 weeks led to an antibody response that was three-and-half times larger than when vaccine doses were kept to the standard recommendation of three weeks apart

Study: Pfizer COVID-19 vaccine doses more effective with a 12-week gap

Pfizer is in discussions with the Indian government seeking an expedited approval pathway for its COVID-19 vaccine, the company’s Chief Executive Officer (CEO) Albert Bourla said on Monday.

Pfizer in talks with Indian govt over expedited approval of COVID-19 vaccine

Pfizer donates 'largest humanitarian relief' worth $70 million to India

Global officials urge rich countries to donate excess COVID-19 vaccines, money to help end the pandemic

Pfizer CEO says third dose of COVID-19 vaccine 'likely' needed within 12 months

BioNTech-Pfizer said that their COVID-19 vaccine showed 100 per cent efficacy against the coronavirus in 12 to 15-year-olds, this comes as the pharma company eye approval for the adolescents to get the jabs before the next school year.

BioNtech-Pfizer say COVID-19 jab 100% effective on 12-15 year olds

Pfizer coronavirus vaccine may be less effective in obesity: Study

Large study shows Pfizer's coronavirus vaccine 94% effective

After snap lockdown, New Zealand begins vaccine programme

EU chief promises extra doses of AstraZeneca and Pfizer-BioNTech vaccine

Novartis to help make Pfizer-BioNTech Covid vaccine

WHO recordings show China delayed releasing coronavirus information

Sanofi to make over 125 million of BioNTech-Pfizer’s Covid vaccine doses

Dubai suffers shipment delays, slows down Pfizer vaccine rollout

France health body recommends delaying second dose of coronavirus vaccine

Extra dose of vaccine can be squeezed out from Pfizer's vial: Reports

WHO says Pfizer's vaccine safe to use as concerns rise post-Norway deaths

Pfizer-BioNTech's vaccine raised hopes, but supply, efficacy concerns are hurting